Title : Activation of PPARĪ“ attenuates neurotoxicity by inhibiting lipopolysaccharide-triggered glutamate release in BV-2 microglial cells.

Pub. Date : 2018 Jul

PMID : 29388693






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Activation of PPARdelta by GW501516, a specific PPARdelta agonist, inhibited glutamate release in BV-2 cells. GW 501516 peroxisome proliferator activator receptor delta Mus musculus
2 Activation of PPARdelta by GW501516, a specific PPARdelta agonist, inhibited glutamate release in BV-2 cells. GW 501516 peroxisome proliferator activator receptor delta Mus musculus
3 This effect of GW501516 was significantly blocked by shRNA-mediated knockdown of PPARdelta and by treatment with GSK0660, a specific PPARdelta antagonist, indicating that PPARdelta is associated with blockade of glutamate release. GW 501516 peroxisome proliferator activator receptor delta Mus musculus
4 This effect of GW501516 was significantly blocked by shRNA-mediated knockdown of PPARdelta and by treatment with GSK0660, a specific PPARdelta antagonist, indicating that PPARdelta is associated with blockade of glutamate release. GW 501516 peroxisome proliferator activator receptor delta Mus musculus
5 This effect of GW501516 was significantly blocked by shRNA-mediated knockdown of PPARdelta and by treatment with GSK0660, a specific PPARdelta antagonist, indicating that PPARdelta is associated with blockade of glutamate release. GW 501516 peroxisome proliferator activator receptor delta Mus musculus
6 Additionally, GW501516-activated PPARdelta suppressed generation of reactive oxygen species and expression of gp91phox, a functional subunit of NADPH oxidase 2, in BV-2 cells stimulated with LPS. GW 501516 peroxisome proliferator activator receptor delta Mus musculus